WHO joins Europe, Merck in recommending against ivermectin for COVID-19
The Peninsula
ZURICH - The World Health Organization (WHO) on Wednesday recommended against using generic anti-parasite drug ivermectin in patients with COVID-19 except for clinical trials, because of a lack of data demonstrating its benefits.
The recommendation follows the European Medicines Agency's warning last week against the drug. The U.S. Food and Drug Administration (FDA) has also recommended it not be used for COVID-19. Officials in the Bolivian city of Trinidad launched a campaign in May last year to give out free doses of ivermectin to combat the coronavirus, although the South American country's health ministry noted the lack of evidence for it as a treatment.
DOHA: Pakistan International School Qatar (PISQ) commemorated Iqbal Day with great passion, respect, and national pride across all its wings, paying t...
Islamic Cultural Center holds lecture on youth empowerment in Islam at Mesaieed International School
Doha, Qatar: With the attendance of 210 students, the Sheikh Abdulla Bin Zaid Al Mahmoud Islamic Cultural Center organised a lecture entitled Youth E...
Doha, Qatar: The Ministry of Public Health (MoPH) has carried out an extensive inspection campaign that included a number of restaurants, cafes, and l...
Washington, USA: Amazon and Google announced the launch of a multi cloud networking service, jointly developed to meet the growing demand for reliable...
Doha, Qatar: Twenty students from the Community College visited the Sheikh Abdulla Bin Zaid Al Mahmoud Islamic Cultural Center, where they learned abo...
London, UK: The Winter egg, one of Faberge s most dazzling creations, is due to be auctioned in London next week and set another sales price record fo...